CULMINATE H - DNA Controls Aging, We Control DNA

What

A wellness conservator engaged in the research, development, and implementation of cellular therapeutic and wellness applications that preserve and extend cellular life.

How

Our robust technological framework is comprised of big data, research, development, genome sequences, and biosensor readings integrated mathematically to classify which specific bioactive compounds and what delivery systems offer the most advantageous anti-aging benefits.

Why

Access to qualitative nutrition from food is sparse and extremely limited. As a direct result our health and longevity are compromised. Our mission and work offer a natural and effective alternative to the food and health crisis ahead. Our ultimate goal is to elevate the human condition.

OUR EVOLUTION

Elevating the human condition

A Profound Possibility

1979-1990.

The successful extraction and use of ultra filtrate peptides comprised of tissues and endocrine glands derived from embryonic opine placenta stem cells.

Give Life To Humans

1980-1995.

Effective hydrolysis reaction through macromolecules ruptures that increase increasing and actuate the appropriate enzymes, suitable pH, and temperature variations to yield a mixture of potent and sophisticated amino acids.

The Recipe To Cell Life

1980-1997.

Optimal fragmentation through hydrolysis yielding a polypeptide, dipeptides, and amnio acids in addition to their natural tissues which contain complex proteins (phosphor-proteins, nucleoproteins, glycoproteins, lipoproteins and metabolic proteins)

Cellular Nutrition

1981-2001.

Optimal yield of supplemental building block components: phosphorus compounds, nucleic acids and nucleotides. All derived from carbohydrates and lipids, biological cofactors, trace elements, and electrolytes, in addition to lysis protein derivatives.

Orthomolecular Revival

1983-2001.

Comprehensive implementation of lysed-process resulting in optimal normalization of structure, physiology, and the metabolism of a particular tissue or organ.

Cellular Optimization

1979-2005.

Optimal cell and regeneration cocktail comprised of tissue / organ specific protein, amino acids, hydrolysates, vitamins, trace elements, minerals, and herbal elements to complement and potentiate the function of the hydrolysates with the placenta stem cells.

Giver Of Life 64: DNA KEY

1979-Present

Successful implementation and administration of proteolytic enzymes to reduce a range of complex proteins, polypeptides, and oligopeptides peptones to achieve maximum absorption of amino acids.

OUR TEAM

An All-Star Team & Board With 100+ Years of combined experience & Success.

Dr. Calixto Vallejo

Co-Founder and Chief Commercial Officer with a proven track record of 30 years in the industry. An expert in strategic leadership, spearheading commercial and operational framework while bridging production, sales, and partner networks. Core competencies include manufacturing and supply chain optimization. With more than three decades of hands-on experience in driving business growth and operational efficiency for fortune 500 organizations this seasoned executive brings a wealth of knowledge in aligning commercial strategies with operational excellence, ensuring seamless integration across all business functions. A key asset in driving sustainable growth and maintaining a competitive edge in today's dynamic business landscape.

Rudy Prajza

Strategic Marketing & Advertising Advisor, Non-Executive Board Member, advises on all strategic marketing and advertising initiatives. This includes consumer analysis and predictive modeling. 40+ years experience in executive marketing and advertisement roles for fortune 500 FMCG conglomerates like Coke and Pepsi.

Armando Mendez

Commercial Financing & Big Box Retailer Strategic Advisor; Non-Executive Board Member, advises on all commercial financing strategies, inventory collaborations, and liquidity as it pertains to big box retailers like Walmart and Target. 40+ experience in executive management within the sport apparel industry holding exclusive licensing with MLB and 30+ years as vendor with Walmart.

Dr. Oscar Kuperman

Strategic Corporate Structure & Finance Advisor, Non-Executive Board Member, advises on all strategic corporate finance strategies and structures. 35+ years experience as accomplished investment banker and corporate finance executive in equity structuring with JB Morgan Chase, Morgan Stanley, Goldman Sachs and Citigroup managing multi-billion dollar funds with a large team of associates.

Cathy Cash Spellman

Strategic Branding & Marketing Advisor, Non-Executive Board Member, advises strategic branding and marketing beauty initiatives, a best seller author with 40+ years experience in VP executive and consulting roles in branding and marketing for fortune 500 beauty and wellness conglomerates.

Stephen Sullivan

Strategic New Product Development & Commercial Advisor, Non-Executive Board Member, advises all strategic new product development and commercialization initiatives with 40+ years experience in ownership and VP of sales within the food and beverage industry working with the largest wine and spirits conglomerates in the world.

Dr. Juan Carlos Rodriguez

Co-Founder, CEO, a highly accomplished C-level executive with 25 years experience in manufacturing, commercialization strategies, input/output analysis, IP strategy/monetization, operational optimization, and financial modeling with fortune 500 companies occupying the energy, life science, biotech, FMCG space. His strategic vision, scientific acumen, financial savvy, and analytical rigor of biophysics and life sciences with the consumer-focused approach of retail products, makes him uniquely qualified to lead Culminate H Labs at the intersection of biotechnology and commercial success.

Gustavo Bravo

Chief Corporate Console oversees the compliance of all contractual documentation, reinforcing our IP strategy/protection (trademarks & patents) while assisting in minimizing exposure & liabilities. Ultimately ensuring CH LABS is preemptive to deescalate any litigious uprising from any/all business relationships and or competitors.

Lisa Capote

FDA Liaison & Console oversees all FDA compliance, claims, and labeling while assisting in minimizing exposure & liabilities to product formulas and brands. Ultimately ensuring CH LABS is preemptive to deescalate any litigious uprising from any/all FDA requirements or business matters.

REFERENCE

Research publications & Case Study References



Center for Cellular Therapy & Cytoplasmic Information and Library Archive; Volume 1, 1076-1982, Cytoplasmic Biology, ovine placenta stem cells.



Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; 2n.d Simposium Cellular Therapy, (1988)



Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 1, (1993)



Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 2, clinical trials, (1993)



Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Nestor E. Bravo, Irene A. Funai; Advances en plastic surgery and repair in the pre and post surgical procedures with molecular nutrition, (1994).



Dr. Santiago Caleque; brief clinical overview in the following cellular and molecular therapies via the use of thymus glands and placenta cotyledon tissues for the mediation of biological conditions, (1996).



Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; a 13 part system outlining molecular therapies specific to organ tissues and their optimal function, (1997).



Dr. Santiago Caleque, Dr. Aaron Erenfryd; cellular and organ therapies via macromolecular nutrition, (1997).



Dr. Santiago Caleque; pluripotent cells revitalization via macromolecular tissue therapies, (1998).



Dr. Santiago Caleque; therapy protocols in molecular tissues, (1999).



Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; blastema tissues, the fundamentals of mesenchymal stem cells (2000).



Dr. Santiago Caleque, Dr. Ruben O. Muhlberger, Dr. Eduardo Arganaras; prophylaxis for aging and metabolic conditions via molecular tissue therapies, (2000)



Dr. Hayde Losa; delivery absorption of hydrolyzed molecular tissue cocktails, (2009)



Dr. Eradio Ignacio Minotti; Advances In Cellular Biology, the human genome, cell Life, & modern integrated Health, (2015).